BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 2573049)

  • 1. A comparison of the cholinergic activity of selected H2-antagonists and sulfoxide metabolites.
    Kosh JW; Sowell JW; Chapman JM
    Pharm Res; 1989 Aug; 6(8):709-13. PubMed ID: 2573049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholinergic effects of histamine-H2 receptor antagonists partly through inhibition of acetylcholinesterase.
    Aono M; Moriga M; Mizuta K; Narusawa H
    Gastroenterol Jpn; 1986 Jun; 21(3):213-9. PubMed ID: 2874096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study of the H2-receptor antagonists cimetidine, ranitidine, famotidine and nizatidine on the rabbit stomach fundus and sigmoid colon.
    Kounenis G; Koutsoviti-Papadopoulou M; Elezoglou A; Voutsas A
    J Pharmacobiodyn; 1992 Oct; 15(10):561-5. PubMed ID: 1362967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of H2-receptor antagonists on gastric alcohol dehydrogenase activity.
    Caballería J; Baraona E; Deulofeu R; Hernández-Muñoz R; Rodés J; Lieber CS
    Dig Dis Sci; 1991 Dec; 36(12):1673-9. PubMed ID: 1684149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inhibition of 24-hour acidity by nizatidine].
    Dammann HG; Dreyer M; Gottlieb WR; Wolf N; Müller P; Simon B
    Fortschr Med; 1989 May; 107(14):321-4. PubMed ID: 2568971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of famotidine with cimetidine and ranitidine.
    Berardi RR; Tankanow RM; Nostrant TT
    Clin Pharm; 1988 Apr; 7(4):271-84. PubMed ID: 2896559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of various histamine H2-receptor antagonists on gastrointestinal motility and gastric emptying].
    Ohira Y; Hanyu N; Aoki T; Hashimoto Y; Iikura M; Fukuda S
    J Smooth Muscle Res; 1993 Aug; 29(4):131-42. PubMed ID: 7907895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct effects of H2-receptor antagonists on airway smooth muscle and on responses mediated by H1- and H2-receptors.
    Koga Y; Iwatsuki N; Hashimoto Y
    Anesthesiology; 1987 Feb; 66(2):181-5. PubMed ID: 2880532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of cimetidine, ranitidine and famotidine on rat hepatic microsomal cytochrome P-450 activities.
    Bast A; Smid K; Timmerman H
    Agents Actions; 1989 Apr; 27(1-2):188-91. PubMed ID: 2568738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatoprotective, antinociceptive and antioxidant activities of cimetidine, ranitidine and famotidine as histamine H2 receptor antagonists.
    Ahmadi A; Ebrahimzadeh MA; Ahmad-Ashrafi S; Karami M; Mahdavi MR; Saravi SS
    Fundam Clin Pharmacol; 2011 Feb; 25(1):72-9. PubMed ID: 20070855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurotoxic convulsions induced by histamine H2 receptor antagonists in mice.
    Shimokawa M; Yamamoto K; Kawakami J; Sawada Y; Iga T
    Toxicol Appl Pharmacol; 1996 Feb; 136(2):317-23. PubMed ID: 8619239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug interactions of H2-receptor antagonists.
    Bachmann KA; Sullivan TJ; Jauregui L; Reese J; Miller K; Levine L
    Scand J Gastroenterol Suppl; 1994; 206():14-9. PubMed ID: 7863246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of cimetidine, ranitidine, and famotidine on human neutrophil functions.
    Mikawa K; Akamatsu H; Nishina K; Shiga M; Maekawa N; Obara H; Niwa Y
    Anesth Analg; 1999 Jul; 89(1):218-24. PubMed ID: 10389808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double blind comparison of the effects of cimetidine, ranitidine, famotidine, and placebo on intragastric acidity in 30 normal volunteers.
    Merki HS; Witzel L; Walt RP; Neumann J; Scheurle E; Mappes A; Krammisch H; Heim J; Kaufmann D; Roehmel J
    Gut; 1988 Jan; 29(1):81-4. PubMed ID: 2893761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of some of the pharmacological properties of etintidine, a new histamine H2-receptor antagonist, with those of cimetidine, ranitidine and tiotidine.
    Cavanagh RL; Usakewicz JJ; Buyniski JP
    J Pharmacol Exp Ther; 1983 Jan; 224(1):171-9. PubMed ID: 6129316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerance during 29 days of conventional dosing with cimetidine, nizatidine, famotidine or ranitidine.
    Nwokolo CU; Smith JT; Gavey C; Sawyerr A; Pounder RE
    Aliment Pharmacol Ther; 1990; 4 Suppl 1():29-45. PubMed ID: 1983345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of antiproliferative effects of 1-histamine-2 receptor antagonists, cimetidine, ranitidine, and famotidine, in gastric cancer cells.
    Hahm KB; Park IS; Kim HC; Lee KJ; Kim JH; Cho SW; Lee SI
    Int J Immunopharmacol; 1996; 18(6-7):393-9. PubMed ID: 9024941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carrier-mediated uptake of H2-receptor antagonists by the rat choroid plexus: involvement of rat organic anion transporter 3.
    Nagata Y; Kusuhara H; Hirono S; Endou H; Sugiyama Y
    Drug Metab Dispos; 2004 Sep; 32(9):1040-7. PubMed ID: 15319347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacology of ORF 17578, a new histamine H2-receptor antagonist: comparison with cimetidine and ranitidine.
    Katz LB; Scott CK; Shriver DA
    J Pharmacol Exp Ther; 1986 May; 237(2):404-10. PubMed ID: 2871172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-oxidant properties of H2-receptor antagonists. Effects on myeloperoxidase-catalysed reactions and hydroxyl radical generation in a ferrous-hydrogen peroxide system.
    van Zyl JM; Kriegler A; van der Walt BJ
    Biochem Pharmacol; 1993 Jun; 45(12):2389-97. PubMed ID: 8101078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.